Lexaria Bioscience Corp (LEXX) Stock Analysis

Lexaria Bioscience Corp (LEXX) is a publicly traded company in the HEALTHCARE sector. It trades at $0.60, carries a market capitalization of $14.92M. This page summarizes the public market data, fundamentals, and frequently asked questions for LEXX, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $0.60
• Market Cap: $14.92M
• EPS: $-0.47
• 52-Week High: $1.55
• 52-Week Low: $0.46

Market Sentiment

Lexaria Bioscience Corp currently has a Bullish sentiment score of 0.21.

About Lexaria Bioscience Corp

Lexaria Bioscience Corp. is a pioneering biotechnology firm headquartered in Kelowna, Canada, specializing in the enhancement of health benefits associated with CBD through its proprietary DehydraTECH™ drug delivery technology. This patented innovation significantly improves the bioavailability of active pharmaceutical ingredients, establishing Lexaria as a leader in the rapidly evolving cannabinoid sector. Committed to extensive research and development, the company seeks to optimize cannabi...

GNG Research Analysis

GNG Research scores Lexaria Bioscience Corp (LEXX) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for LEXX.

Frequently Asked Questions

Does LEXX pay dividends?

Lexaria Bioscience Corp (LEXX) does not currently pay a regular dividend.

What is LEXX's market cap?

Lexaria Bioscience Corp (LEXX) has a market capitalization of $14.92M with a current stock price of $0.60.